Speculation2 Jan 2024 09:32
Whilst pure speculation on my part; I would not be the least bit surprised if the licencing deal announced today by Sareum Holdings plc with a US Private Equity Company didn't actually involve Nick Glover being somewhere in the mix (i.e. the ex CEO of ProNAi Therapeutics and Sierra Oncology) and if so, then this is indeed fantastic news for Sareum shareholders, as no one is more acutely aware and intimately informed of SRA737's multi-applicable disease targeting properties and potential than is Nick Glover and his drive, focus and passion in progressing this compound with the utmost haste is precisely what is now required.
Nice to be proven wrong about 737
GLA